Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $587.0900 (2.83%) ($571.4000 - $588.9800) on Wed. Nov. 18, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 62 | Latest Price | $587.0900(2.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | Factors Impacting REGN price | REGN will decline at least -1.445% in a week (0% probabilities). VIXM(-14%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
5 Day Moving Average | $563.56(4.18%) | 10 Day Moving Average | $563.6(4.17%) | 20 Day Moving Average | $561.34(4.59%) | To recent high | 0% | To recent low | 29.9% | Market Cap | $62.248b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |